
pseudoephedrine-dextromethorphan-guaifen-acetaminophen oral brand names and other generic formulations include:
Cough Formula 4-M Oral, Cough Formula M Oral, Day Time (with Guaifenesin) Oral, Day Time Liquid Caps Oral, Day Time Liquid Cold Oral, Day Time Liquid Gels Oral, Daycare Oral, Daytime Non-Drowsy Cold/Flu Oral, D-Congest M Oral, Duraflu Oral, Flutabs Oral, Maxiflu DM Oral, Maxiflu G Oral, Multi Symptom Cold Relief Oral, Multi-Symptom Cough-Cold Oral, Multi-Symptom Oral, Multi-Symptom Pain Relief Oral, Multi-Symptom Su-Phedrin Oral, Non-ASA Severe Cold Congestion Oral, Non-Aspirin Cold Caplet Oral, Non-Drowsy Cold-Congestion Oral, Pain Reliever Cold Caplet Oral, Phlemgesic Oral, Pseudoephedrine Cold & Cough Oral, Pseudoephedrine Max Strength Oral, Severe Cold-Congestion Oral, Sudafed Cold-Cough Oral, Suphedrin Cough & Cold Oral, Suphedrine Cough & Cold Oral, Theraflu Max-D Severe Cold-Flu Oral, Tusnel-A Oral, Vicks Daycare Oral, Vicks DayQuil Liquicaps Oral, Wal-Tussin Cold & Flu Oral
iobenguane sulfate i-123 iv brand names and other generic formulations include:
pseudoephedrine-dextromethorphan-guaifen-acetaminophen oral and iobenguane sulfate i-123 iv
pseudoephedrine-dextromethorphan-guaifen-acetaminophen oral decreases effects of iobenguane sulfate i-123 iv by the drugs competing for binding to the location in the body that is targeted by these drugs. Combination may cause false-negative imaging results.
pseudoephedrine-dextromethorphan-guaifen-acetaminophen oral and iobenguane sulfate i-123 iv
pseudoephedrine-dextromethorphan-guaifen-acetaminophen oral decreases effects of iobenguane sulfate i-123 iv by receptor binding competition. If clinically appropriate, discontinue drugs that compete for NE receptor sites for at least 5 half-lives; may cause false-negative imaging results. Do not administer pseudoephedrine until at least 7 days after each iobenguane dose.
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant